The leading cause of death in the juvenile population is trauma, and in particular neurotrauma. The juvenile brain response to neurotrauma is not completely understood. Endoplasmic reticulum (ER) stress has been shown to contribute to injury expansion and behavioral deficits in adult rodents and furthermore has been seen in adult postmortem human brains diagnosed with chronic traumatic encephalopathy. Whether endoplasmic reticulum stress is increased in juveniles with traumatic brain injury (TBI) is poorly delineated. We investigated this important topic using a juvenile rat controlled cortical impact (CCI) model. We proposed that ER stress would be significantly increased in juvenile rats following TBI and that this would correlate with behavioral deficits using a juvenile rat model. A juvenile rat (postnatal day 28) CCI model was used. Binding immunoglobulin protein (BiP) and C/EBP homologous protein (CHOP) were measured at 4 h in the ipsilateral pericontusion cortex. Hypoxia-inducible factor (HIF)-1α was measured at 48 h and tau kinase measured at 1 week and 30 days. At 4 h following injury, BiP and CHOP (markers of ER stress) were significantly elevated in rats exposed to TBI. We also found that HIF-1α was significantly upregulated 48 h following TBI showing delayed hypoxia. The early ER stress activation was additionally asso-ciated with the activation of a known tau kinase, glycogen synthase kinase-3β (GSK-3β), by 1 week. Tau oligomers measured by R23 were significantly increased by 30 days following TBI. The biochemical changes following TBI were associated with increased impulsive-like or anti-anxiety behavior measured with the elevated plus maze, deficits in short-term memory measured with novel object recognition, and deficits in spatial memory measured with the Morris water maze in juvenile rats exposed to TBI. These results show that ER stress was increased early in juvenile rats exposed to TBI, that these rats developed tau oligomers over the course of 30 days, and that they had significant short-term and spatial memory deficits following injury.

1.
Pinto PS, Poretti A, Meoded A, Tekes A, Huisman TA: The unique features of traumatic brain injury in children. Review of the characteristics of the pediatric skull and brain, mechanisms of trauma, patterns of injury, complications and their imaging findings. Part 1. J Neuroimag 2012; 22:e1–e17.
2.
Pinto PS, Meoded A, Poretti A, Tekes A, Huisman TA: The unique features of traumatic brain injury in children. Review of the characteristics of the pediatric skull and brain, mechanisms of trauma, patterns of injury, complications, and their imaging findings. Part 2. J Neuroimag 2012; 22:e18–e41.
3.
Claus CP, Tsuru-Aoyagi K, Adwanikar H, Walker B, Manvelyan H, Whetstone W, Noble-Haeusslein LJ: Age is a determinant of leukocyte infiltration and loss of cortical volume after traumatic brain injury. Dev Neurosci 2010; 32: 454–465.
4.
Hu BR, Liu CL, Ouyang Y, Blomgren K, Siesjo BK: Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 2000; 20: 1294–1300.
5.
Semple BD, Noble-Haeusslein LJ, Jun Kwon Y, Sam PN, Gibson AM, Grissom S, Brown S, Adahman Z, Hollingsworth CA, Kwakye A, Gimlin K, Wilde EA, Hanten G, Levin HS, Schenk AK: Sociosexual and communication deficits after traumatic injury to the developing murine brain. PLoS One 2014; 9:e103386.
6.
Jantzie LL, Talos DM, Jackson MC, Park HK, Graham DA, Lechpammer M, Folkerth RD, Volpe JJ, Jensen FE: Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain. Cereb Cortex 2015; 25: 482–495.
7.
Giza CC, Prins ML, Hovda DA, Herschman HR, Feldman JD: Genes preferentially induced by depolarization after concussive brain injury: effects of age and injury severity. J Neurotrauma 2002; 19: 387–402.
8.
Giza CC, Maria NS, Hovda DA: N-methyl-D-aspartate receptor subunit changes after traumatic injury to the developing brain. J Neurotrauma 2006; 23: 950–961.
9.
Osteen CL, Giza CC, Hovda DA: Injury-induced alterations in N-methyl-D-aspartate receptor subunit composition contribute to prolonged 45calcium accumulation following lateral fluid percussion. Neuroscience 2004; 128: 305–322.
10.
Gaudet CM, Lim YP, Stonestreet BS, Threlkeld SW: Effects of age, experience and inter-alpha inhibitor proteins on working memory and neuronal plasticity after neonatal hypoxia-ischemia. Behav Brain Res 2016; 302: 88–99.
11.
Prins ML, Hovda DA: Traumatic brain injury in the developing rat: effects of maturation on Morris water maze acquisition. J Neurotrauma 1998; 15: 799–811.
12.
Max JE, Schachar RJ, Levin HS, Ewing-Cobbs L, Chapman SB, Dennis M, Saunders A, Landis J: Predictors of secondary attention-deficit/hyperactivity disorder in children and adolescents 6 to 24 months after traumatic brain injury. J Am Acad Child Adolescent Psychiatry 2005; 44: 1041–1049.
13.
Max JE, Lindgren SD, Knutson C, Pearson CS, Ihrig D, Welborn A: Child and adolescent traumatic brain injury: correlates of disruptive behaviour disorders. Brain Injury 1998; 12: 41–52.
14.
Schmidt AT, Hanten GR, Li X, Vasquez AC, Wilde EA, Chapman SB, Levin HS: Decision making after pediatric traumatic brain injury: trajectory of recovery and relationship to age and gender. Int J Dev Neurosci 2012; 30: 225–230.
15.
Brooks BL, Daya H, Khan S, Carlson HL, Mikrogianakis A, Barlow KM: Cognition in the emergency department as a predictor of recovery after pediatric mild traumatic brain injury. J Int Neuropsychol Soc 2016; 22: 379–387.
16.
Plourde V, Brooks BL: Is computerized cognitive testing useful in children and adolescents with moderate-to-severe traumatic brain injury? J Int Neuropsychol Soc 2017; 23: 304–313.
17.
Larner SF, Hayes RL, Wang KK: Unfolded protein response after neurotrauma. J Neurotrauma 2006; 23: 807–829.
18.
Begum G, Harvey L, Dixon CE, Sun D: ER stress and effects of DHA as an ER stress inhibitor. Transl Stroke Res 2013; 4: 635–642.
19.
Logsdon AF, Lucke-Wold BP, Nguyen L, Matsumoto RR, Turner RC, Rosen CL, Huber JD: Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury. Brain Res 2016; 1643: 140–151.
20.
Dash PK, Hylin MJ, Hood KN, Orsi SA, Zhao J, Redell JB, Tsvetkov AS, Moore AN: Inhibition of eukaryotic initiation factor 2 alpha phosphatase reduces tissue damage and improves learning and memory after experimental traumatic brain injury. J Neurotrauma 2015; 32: 1608–1620.
21.
Golpich M, Amini E, Hemmati F, Ibrahim NM, Rahmani B, Mohamed Z, Raymond AA, Dargahi L, Ghasemi R, Ahmadiani A: Glycogen synthase kinase-3 beta (GSK-3beta) signaling: implications for Parkinson’s disease. Pharmacol Res 2015; 97: 16–26.
22.
Kovacs K, Decatur C, Toro M, Pham DG, Liu H, Jing Y, Murray TG, Lampidis TJ, Merchan JR: 2-Deoxy-glucose downregulates endothelial AKT and ERK via interference with N-linked glycosylation, induction of endoplasmic reticulum stress, and GSK3beta activation. Mol Cancer Ther 2016; 15: 264–275.
23.
Meares GP, Mines MA, Beurel E, Eom TY, Song L, Zmijewska AA, Jope RS: Glycogen synthase kinase-3 regulates endoplasmic reticulum (ER) stress-induced CHOP expression in neuronal cells. Exp Cell Res 2011; 317: 1621–1628.
24.
Lucke-Wold BP, Turner RC, Logsdon AF, Nguyen L, Bailes JE, Lee JM, Robson MJ, Omalu BI, Huber JD, Rosen CL: Endoplasmic reticulum stress implicated in chronic traumatic encephalopathy. J Neurosurg 2016; 124: 687–702.
25.
Chavez-Valdez R, Flock DL, Martin LJ, Northington FJ: Endoplasmic reticulum pathology and stress response in neurons precede programmed necrosis after neonatal hypoxia-ischemia. Int J Dev Neurosci 2016; 48: 58–70.
26.
Cai XH, Li XC, Jin SW, Liang DS, Wen ZW, Cao HC, Mei HF, Wu Y, Lin ZD, Wang LX: Endoplasmic reticulum stress plays critical role in brain damage after chronic intermittent hypoxia in growing rats. Exp Neurol 2014; 257: 148–156.
27.
Bueter W, Dammann O, Leviton A: Endoplasmic reticulum stress, inflammation, and perinatal brain damage. Pediatr Res 2009; 66: 487–494.
28.
Han Y, Yi W, Qin J, Zhao Y, Zhang J, Chang X: Carbon monoxide offers neuroprotection from hippocampal cell damage induced by recurrent febrile seizures through the PERK-activated ER stress pathway. Neurosci Lett 2015; 585: 126–131.
29.
Semple BD, Blomgren K, Gimlin K, Ferriero DM, Noble-Haeusslein LJ: Brain development in rodents and humans: identifying benchmarks of maturation and vulnerability to injury across species. Prog Neurobiol 2013; 106–107: 1–16.
30.
Von Bergen M, Barghorn S, Muller SA, Pickhardt M, Biernat J, Mandelkow EM, Davies P, Aebi U, Mandelkow E: The core of tau-paired helical filaments studied by scanning transmission electron microscopy and limited proteolysis. Biochemistry 2006; 45: 6446–6457.
31.
Lucke-Wold BP, Naser ZJ, Logsdon AF, Turner RC, Smith KE, Robson MJ, Bailes JE, Lee JM, Rosen CL, Huber JD: Amelioration of nicotinamide adenine dinucleotide phosphate-oxidase mediated stress reduces cell death after blast-induced traumatic brain injury. Transl Res 2015; 166: 509–528. e501.
32.
Dash PK, Zhao J, Kobori N, Redell JB, Hylin MJ, Hood KN, Moore AN: Activation of alpha 7 cholinergic nicotinic receptors reduce blood-brain barrier permeability following experimental traumatic brain injury. J Neurosci 2016; 36: 2809–2818.
33.
Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL: A controlled cortical impact model of traumatic brain injury in the rat. J Neurosci Methods 1991; 39: 253–262.
34.
Dash PK, Hylin MJ, Hood KN, Orsi SA, Zhao J, Redell JB, Tsvetkov AS, Moore AN: Inhibition of eukaryotic initiation factor 2 alpha phosphatase reduces tissue damage and improves learning and memory after experimental traumatic brain injury. J Neurotrauma 2015; 32: 1608–1620.
35.
Mao H, Jin X, Zhang L, Yang KH, Igarashi T, Noble-Haeusslein LJ, King AI: Finite element analysis of controlled cortical impact-induced cell loss. J Neurotrauma 2010; 27: 877–888.
36.
Mao H, Yang KH, King AI, Yang K: Computational neurotrauma – design, simulation, and analysis of controlled cortical impact model. Biomech Model Mechanobiol 2010; 9: 763–772.
37.
Mao H, Zhang L, Yang KH, King AI: Application of a finite element model of the brain to study traumatic brain injury mechanisms in the rat. Stapp Car Crash J 2006; 50: 583–600.
38.
Meaney DF, Ross DT, Winkelstein BA, Brasko J, Goldstein D, Bilston LB, Thibault LE, Gennarelli TA: Modification of the cortical impact model to produce axonal injury in the rat cerebral cortex. J Neurotrauma 1994; 11: 599–612.
39.
Martens KM, Vonder Haar C, Hutsell BA, Hoane MR: A discrimination task used as a novel method of testing decision-making behavior following traumatic brain injury. J Neurotrauma 2012; 29: 2505–2512.
40.
Cole JT, Yarnell A, Kean WS, Gold E, Lewis B, Ren M, McMullen DC, Jacobowitz DM, Pollard HB, O’Neill JT, Grunberg NE, Dalgard CL, Frank JA, Watson WD: Craniotomy: true sham for traumatic brain injury, or a sham of a sham? J Neurotrauma 2011; 28: 359–369.
41.
Bevins RA, Besheer J: Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study “recognition memory.” Nat Protoc 2006; 1: 1306–1311.
42.
Eakin K, Baratz-Goldstein R, Pick CG, Zindel O, Balaban CD, Hoffer ME, Lockwood M, Miller J, Hoffer BJ: Efficacy of N-acetyl cysteine in traumatic brain injury. PLoS One 2014; 9:e90617.
43.
Sta Maria NS, Reger ML, Cai Y, Baquing MAT, Buen F, Ponnaluri A, Hovda DA, Harris NG, Giza CC: D-Cycloserine restores experience-dependent neuroplasticity after traumatic brain injury in the developing rat brain. J Neurotrauma 2017; 34: 1692–1702.
44.
Komada M, Takao K, Miyakawa T: Elevated plus maze for mice. J Vis Exp 2008; 22: 1088.
45.
Cheng JS, Craft R, Yu GQ, Ho K, Wang X, Mohan G, Mangnitsky S, Ponnusamy R, Mucke L: Tau reduction diminishes spatial learning and memory deficits after mild repetitive traumatic brain injury in mice. PLoS One 2014; 9:e115765.
46.
Dash PK, Mach SA, Moore AN: The role of extracellular signal-regulated kinase in cognitive and motor deficits following experimental traumatic brain injury. Neuroscience 2002; 114: 755–767.
47.
Harish G, Mahadevan A, Pruthi N, Sreenivasamurthy SK, Puttamallesh VN, Keshava Prasad TS, Shankar SK, Srinivas Bharath MM: Characterization of traumatic brain injury in human brains reveals distinct cellular and molecular changes in contusion and pericontusion. J Neurochem 2015; 134: 156–172.
48.
Harris NG, Mironova YA, Hovda DA, Sutton RL: Chondroitinase ABC enhances pericontusion axonal sprouting but does not confer robust improvements in behavioral recovery. J Neurotrauma 2010; 27: 1971–1982.
49.
Harris NG, Mironova YA, Hovda DA, Sutton RL: Pericontusion axon sprouting is spatially and temporally consistent with a growth-permissive environment after traumatic brain injury. J Neuropathol Exp Neurol 2010; 69: 139–154.
50.
Lucke-Wold BP, Logsdon AF, Smith KE, Turner RC, Alkon DL, Tan Z, Naser ZJ, Knotts CM, Huber JD, Rosen CL: Bryostatin-1 restores blood brain barrier integrity following blast-induced traumatic brain injury. Mol Neurobiol 2015; 52: 1119–1134.
51.
Harris NG, Verley DR, Gutman BA, Thompson PM, Yeh HJ, Brown JA: Disconnection and hyper-connectivity underlie reorganization after TBI: a rodent functional connectomic analysis. Exp Neurol 2016; 277: 124–138.
52.
Csiszar A, Ungvari Z, Edwards JG, Kaminski P, Wolin MS, Koller A, Kaley G: Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res 2002; 90: 1159–1166.
53.
McCullough KD, Martindale JL, Klotz LO, Aw TY, Holbrook NJ: Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2 and perturbing the cellular redox state. Mol Cell Biol 2001; 21: 1249–1259.
54.
Logsdon AF, Turner RC, Lucke-Wold BP, Robson MJ, Naser ZJ, Smith KE, Matsumoto RR, Huber JD, Rosen CL: Altering endoplasmic reticulum stress in a model of blast-induced traumatic brain injury controls cellular fate and ameliorates neuropsychiatric symptoms. Front Cell Neurosci 2014; 8: 421.
55.
Tatebayashi Y, Haque N, Tung YC, Iqbal K, Grundke-Iqbal I: Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport. J Cell Sci 2004; 117: 1653–1663.
56.
D’Abramo C, Acker CM, Jimenez HT, Davies P: Tau passive immunotherapy in mutant P301L mice: antibody affinity versus specificity. PLoS One 2013; 8:e62402.
57.
Pikstra AR, Metting Z, Fock JM, van der Naalt J: The juvenile head trauma syndrome – deterioration after mild TBI: diagnosis and clinical presentation at the emergency department. Eur J Paediatr Neurol 2017; 21: 344–349.
58.
Logsdon AF, Lucke-Wold BP, Rosen CL, Huber JD: Disparity among neural injury models and the unfolded protein response. J Neurol Disord Stroke 2014; 2: 1074.
59.
Licht-Murava A, Paz R, Vaks L, Avrahami L, Plotkin B, Eisenstein M, Eldar-Finkelman H: A unique type of GSK-3 inhibitor brings new opportunities to the clinic. Sci Signal 2016; 9:ra110.
60.
Kriegel J, Papadopoulos Z, McKee AC: Chronic traumatic encephalopathy: is latency in symptom onset explained by tau propagation? Cold Spring Harb Perspect Med 2018; 8:a024059.
61.
Rong LL, Huang HC, Yu L, Li JZ: Hypoxia stimulates expression of connective tissue growth factor through p38 signaling pathway in human renal interstitial fibroblasts (in Chinese). Beijing Da Xue Xue Bao 2005; 37: 378–381.
62.
Salomon-Zimri S, Glat MJ, Barhum Y, Luz I, Boehm-Cagan A, Liraz O, Ben-Zur T, Offen D, Michaelson DM: Reversal of ApoE4-driven brain pathology by vascular endothelial growth factor treatment. J Alzheimers Dis 2016; 53: 1443–1458.
63.
Weil ZM, Karelina K, Gaier KR, Corrigan TE, Corrigan JD: Juvenile traumatic brain injury increases alcohol consumption and reward in female mice. J Neurotrauma 2016; 33: 895–903.
64.
Mychasiuk R, Hehar H, Esser MJ: A mild traumatic brain injury (mTBI) induces secondary attention-deficit hyperactivity disorder-like symptomology in young rats. Behav Brain Res 2015; 286: 285–292.
65.
Gordon WA, Spielman LA, Hahn-Ketter AE, Sy KT: The relationship between traumatic brain injury and criminality in juvenile offenders. J Head Trauma Rehabil 2017; 32: 393–403.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.